(Q39180818)

English

Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death.

scientific article published on 14 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495229%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495229%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495229%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Francois Ghiringhelli

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495229%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

Virginie Aires

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495229%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Emeric Limagne

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495229%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Norbert Latruffe

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495229%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Dominique Delmas

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495229%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

14 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495229%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Molecular Nutrition and Food Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495229%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

57

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495229%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495229%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1170-1181

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495229%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Postterm delivery: a challenge for epidemiologic research

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Resveratrol: preventing properties against vascular alterations and ageing

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

The cardiovascular nutrapharmacology of resveratrol: pharmacokinetics, molecular mechanisms and therapeutic potential.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Inhibitory effects of trans-resveratrol analogs molecules on the proliferation and the cell cycle progression of human colon tumoral cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Therapeutic potential of resveratrol: the in vivo evidence

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Role of membrane dynamics processes and exogenous molecules in cellular resveratrol uptake: consequences in bioavailability and activities

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Metabolism and bioavailability of trans-resveratrol.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

High absorption but very low bioavailability of oral resveratrol in humans

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Clinical trials of resveratrol

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Time-dependent resveratrol-mediated mRNA and protein expression associated with cell cycle in WR-21 cells containing mutated human c-Ha-Ras

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Resveratrol modulates DNA double-strand break repair pathways in an ATM/ATR-p53- and -Nbs1-dependent manner

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

New Topoisomerase I mutations are associated with resistance to camptothecin

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Resveratrol bioavailability and toxicity in humans

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Dietary phenolics: chemistry, bioavailability and effects on health

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Pleiotropic mechanisms facilitated by resveratrol and its metabolites.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Widdrol activates DNA damage checkpoint through the signaling Chk2-p53-Cdc25A-p21-MCM4 pathway in HT29 cells.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200766

21 January 2018

Identifiers

10.1002/MNFR.201200766

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495229%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495229%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39180818&oldid=1719123530"